BNP plans to price buffered return enhanced notes on biotech ETF

By Emma Trincal

New York, July 6 – BNP Paribas plans to price 0% buffered return enhanced notes due July 17, 2023 linked to the SPDR S&P Biotech exchange-traded fund, according to a term sheet.

The payout at maturity will be par plus 3 times any gain of the ETF.

Investors will receive par if the ETF falls by up to 20% and will lose 1.25% per 1% drop beyond 20%.

The notes will be guaranteed by BNP Paribas acting through its NY Branch.

BNP Paribas Securities Corp. is the agent.

The notes will price on July 10 and settle on July 15.

The Cusip number is 05583R3T9.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.